Hirofumi Kusaka

Mutations of optineurin in amyotrophic lateral sclerosis

Hirofumi Maruyama, Hiroyuki Morino, Hidefumi Ito et al. · Nature · 2010 · 1.2K citations

Amyotrophic Lateral Sclerosis, Neurological Disorder, Neurology +4

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

Koji Abe, Masashi Aoki, Shoji Tsuji et al. · The Lancet Neurology · 2017 · 900 citations

Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis, Neurological Disorder +6

FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations

Manuela Neumann, Eva Bentmann, Dorothee Dormann et al. · Brain · 2011 · 304 citations · Full text

Fus Pathology, Amyotrophic Lateral Sclerosis, Mendelian Disorder +12

FUS pathology in basophilic inclusion body disease

David G. Muñoz, Manuela Neumann, Hirofumi Kusaka et al. · Acta Neuropathologica · 2009 · 244 citations · Full text

Fus Pathology, Autoimmune Disease, Disease Mechanism +7

Distinct pathological subtypes of FTLD-FUS

Ian R. Mackenzie, David G. Muñoz, Hirofumi Kusaka et al. · Acta Neuropathologica · 2010 · 169 citations

Mendelian Disorder, Genetic Disorder, Genetics +6